ACTRN12620001173987进行中(未招募)未知
Optimising outcomes for frail hospitalised older adults – nurse led volunteer support and pain assessment interventions: A cluster randomised control trial
试验速览
- 阶段
- 未知
- 状态
- 进行中(未招募)
- 入组人数
- 421
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 65 Years 至 o limit(—)
- 性别
- All
入选标准
- •Patients aged 65 years and over admitted to participating wards
- •Anticipated length of hospital stay 48 hours or longer
- •Score greater than or equal to 8 on the modified-Reported Edmonton Frail Scale (mod-REFS)
排除标准
- •Non-medical patient
- •Severe intellectual disability
- •Patients who requires isolation due to infection control precautions
研究者
相似试验
已完成
不适用
Optimising acute delirium care in Tan Tock Seng HospitalISRCTN52323811Ministry of Health (Singapore)200
已完成
不适用
Developing better care for the elderly patients with walking disability due to degenerative lumbar spine stenosisISRCTN35836727Record Provided by the NHSTCT Register - 2006 Update - Department of Health20
已完成
不适用
Minimising functional decline amongst older adults with a novel intervention against a traditional intervention.ACTRN12610000909022Singhealth Foundation40
进行中(未招募)
1 期
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.EUCTR2016-002272-27-BESaarland University388
进行中(未招募)
1 期
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.Patients with first relapse or progression of aggressive Non-Hodgkin’s Lymphoma who are not eligible neither for autologous nor allogeneic stem cell transplantationMedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-002272-27-ATSaarland University388
